← Leaderboards
Remi Buisson
Massachusetts General Hospital
$3,888,194
Attributed
$3,888,194
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,888,194 · 6
By mechanism
R37$2,176,422 · 1
R00$747,000 · 1
R21$660,185 · 2
K99$284,587 · 1
R13$20,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Richard C. Centore$152,478
- Norman S Nishioka$0
- Nir Hacohen$29,379,938
- Jason Allen West$140,671
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsDna DamageGenomic InstabilityCellsPathway InteractionsDna RepairMutationCancer TypeGenomeSourceCancer CellDna BiosynthesisGenomicsChemotherapyMemberSignal TransductionPreventRegulationMutagenesisSignal PathwayLeadDeaminationCytosineFamily
Grant awards (18)
NF-KB regulation by the DNA damage response$431,750
R21 · FY2025 · ES · contact PI
Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer$337,605
R37 · FY2025 · CA · contact PI
Role of APOBEC3B in the Innate Immune Response$228,435
R21 · FY2025 · AI · contact PI
Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer$97,648
R37 · FY2025 · CA · contact PI
Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer$326,014
R37 · FY2024 · CA · contact PI
Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer$96,763
R37 · FY2024 · CA · contact PI
Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer$79,219
R37 · FY2024 · CA · contact PI
Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer$341,474
R37 · FY2023 · CA · contact PI
Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer$81,721
R37 · FY2023 · CA · contact PI
2022 SoCal Genome Stability Symposium$20,000
R13 · FY2023 · CA · contact PI
Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer$371,329
R37 · FY2022 · CA · contact PI
Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer$83,389
R37 · FY2022 · CA · contact PI
Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer$361,260
R37 · FY2021 · CA · contact PI
TARGETING APOBEC3A-EXPRESSING CANCER CELLS WITH ATR INHIBITORS$249,000
R00 · FY2020 · CA · contact PI
TARGETING APOBEC3A-EXPRESSING CANCER CELLS WITH ATR INHIBITORS$249,000
R00 · FY2019 · CA · contact PI
TARGETING APOBEC3A-EXPRESSING CANCER CELLS WITH ATR INHIBITORS$249,000
R00 · FY2018 · CA · contact PI
Targeting APOBEC3A-expressing cancer cells with ATR inhibitors$142,027
K99 · FY2018 · CA · contact PI
Targeting APOBEC3A-expressing cancer cells with ATR inhibitors$142,560
K99 · FY2017 · CA · contact PI